Abstract
In a trial involving patients with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the risk of worsening heart failure or cardiovascular death.
- Title
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- Creators - without role
- Scott D. Solomon - British Heart FoundationJohn J.V. McMurray - University of GlasgowBrian Claggett - British Heart FoundationRudolf A. de Boer - British Heart FoundationDavid DeMets - British Heart FoundationAdrian F. Hernandez - British Heart FoundationSilvio E. Inzucchi - British Heart FoundationMikhail N. Kosiborod - British Heart FoundationCarolyn S.P. Lam - British Heart FoundationFelipe Martinez - British Heart FoundationSanjiv J. Shah - British Heart FoundationAkshay S. Desai - British Heart FoundationPardeep S. Jhund - British Heart FoundationJan Belohlavek - British Heart FoundationChern-En Chiang - British Heart FoundationC. Jan Willem Borleffs - British Heart FoundationJosep Comin-Colet - British Heart FoundationDan Dobreanu - British Heart FoundationJaroslaw DrozdzJames C. Fang - British Heart FoundationMarco Antonio Alcocer-Gamba - British Heart FoundationWaleed Al Habeeb - British Heart FoundationYaling Han - British Heart FoundationJose Walter Cabrera HonorioStefan P. Janssens - British Heart FoundationTzvetana Katova - British Heart FoundationMasafumi Kitakaze - British Heart FoundationBéla Merkely - British Heart FoundationEileen O’MearaJose Francisco Kerr Saraiva - British Heart FoundationSergey N. Tereshchenko - British Heart FoundationJorge Thierer - British Heart FoundationMuthiah Vaduganathan - British Heart FoundationOrly Vardeny - British Heart FoundationSubodh Verma - British Heart FoundationVinh Nguyen Pham - British Heart FoundationUlrica Wilderäng - British Heart FoundationNatalia Zaozerska - British Heart FoundationErasmus Bachus - British Heart FoundationDaniel Lindholm - British Heart FoundationMagnus Petersson - British Heart FoundationAnna Maria Langkilde - British Heart FoundationDELIVER Trial Comm Investigators
- Publication Details
- The New England journal of medicine, Vol.387(12), pp.1089-1098
- Publisher
- Massachusetts Medical Society
- Identifiers
- 9948675308331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article